Physical Activity, Motor Competence, Pulmonary Function, and Quality of Life in Children With Severe Spinal Disease

September 17, 2021 updated by: Thomas Johan Kibsgård, Oslo University Hospital
Observation study about physical activity, motor competence, pulmonary function, and health related quality of life in children, surgically treated for early onset scoliosis

Study Overview

Detailed Description

Early Onset Scoliosis (EOS) defines patients who develop deformities of the spine and/or thorax in the embryologic development or in the early childhood. The exact prevalence of EOS in Norway is unknown, but it is assumed to be approximately 200-300 new EOS patients every year. EOS is a severe condition, whereby some of the most common and also most severe consequences of the deformity are severe pulmonary problems. The patients may require extensive orthopedic treatment from early childhood and until maturity to avoid serious consequences with severe pulmonary problems and shortening of life.

EOS' secondary problems, including severe consequences on the pulmonary function might contribute to enhanced inactivity. Inactivity contributes to further negative impact on development of the musculoskeletal system, motor competence and pulmonary function. Considering the severity of EOS and children's reduced life expectancy, it is extremely important that EOS children achieve the favorable impact of physical activity during their growth. Insufficient level of activity might worsen the prognosis, thus counteracting the treatment's ambitions. The investigator's aim is to extend the knowledge about level of activity, motor competence, pulmonary function, and health related quality of life in Norwegian children, surgically treated for EOS.

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Oslo, Norway, 0372
        • Oslo University Hospital, Rikshospitalet

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 20 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Children treated at the Norwegian National Unit for Surgical Treatment of Non-malignant Pathologies in Pediatric Spine, Oslo University Hospital

Description

Inclusion Criteria:

  • Early onset scoliosis diagnosis
  • Understand and speak Norwegian
  • For physical activity test: Walking ability
  • For motor competence test and/or pulmonary function test: Ability to understand the test and cooperate

Exclusion Criteria:

  • Other spinal disease, not early onset scoliosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical Activity, assessed by use of accelerometer
Time Frame: Change in activity counts from baseline to activity counts at 6 months and 12 months.
Physical Activity will be measured objective by use of an accelerometer (used over 7 days), recorded as Activity Counts/ minutes
Change in activity counts from baseline to activity counts at 6 months and 12 months.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Airway resistance, assessed by use of plethysmography
Time Frame: Change in measures from baseline and to 12 months
Children >8 years will also be assessed by use of plethysmography. Airway resistance will be measured, recorded as the ratio of driving pressure divided by flow through the airways
Change in measures from baseline and to 12 months
Pulmonary residual volume and total lung capacity, assessed by use of plethysmography
Time Frame: Change in measures from baseline and to 12 months
Children >8 years will also be assessed by use of plethysmography. Residual volume (liters) and total lung capacity (liters) will be measured.
Change in measures from baseline and to 12 months
Pulmonary function, assessed by use of diffusion capacity test
Time Frame: Change in measures from baseline and to 12 months
Children >8 years will be assessed by use of diffusion capacity test. Diffusing capacity or transfer factor of the lung for carbon monoxide (CO) (DLCO) will be measured.
Change in measures from baseline and to 12 months
Pulmonary function, assessed by use of spirometry
Time Frame: Change in measures from baseline and to 12 months
All participants will go through spirometry. Vital capacity (VC), Forced vital capacity (FVC), Forced expiratory volume (FEV) at timed intervals of 0.5, 1.0 (FEV1), 2.0, and 3.0 seconds and maximal voluntary ventilation (MVV) will be measured (liters)
Change in measures from baseline and to 12 months
Forced expiratory flow, assessed by use of spirometry
Time Frame: Change in measures from baseline and to 12 months
All participants will go through spirometry. Forced expiratory flow 25-75% (FEF 25-75) will be measured (liters/second)
Change in measures from baseline and to 12 months
Motor competence, assessed by use of Movement Assessment Battery of Children- 2. edition
Time Frame: Baseline and after 12 months
Motor competence will be assessed by use of Movement Assessment Battery of Children- 2. edition
Baseline and after 12 months
Health related quality of life in children
Time Frame: Change in parents answers of health related quality of life of their child from baseline, to 6 months and to 12 months.
Health related quality of life will be assessed by use of the Early Onset Scoliosis 24-item Questionnaire (EOSQ-24). Total score, ranged 0 (worst) to 100 (best), including 11 subdomain scores, ranged 0 (worst) to 100 (best) will be calculated.
Change in parents answers of health related quality of life of their child from baseline, to 6 months and to 12 months.
Health related quality of life in adolescents
Time Frame: Change in subjective answers of health related quality of life from baseline, to 6 mounts and to 12 mounts.
Among participants > 16 years, health related quality of life will be assessed by use of the Scoliosis Research Society 22- item (SRS-22) questionnaire. Total score and 5 subdomain scores, all ranged 5 (best) to 1 (worst), will be calculated.
Change in subjective answers of health related quality of life from baseline, to 6 mounts and to 12 mounts.
Shoulder function
Time Frame: Baseline and after 12 months
A physiotherapist will assess the active shoulder range of motion, categorized as normal, active range of motion >50% of perceived motion, or active range of motion <50% of perceived motion. shoulder flexion, extension, abduction, and rotation will be measured.
Baseline and after 12 months
Physical Activity, assessed by use of questionnaire
Time Frame: Change in subjective answers of everyday activity from baseline, to 6 mounts and to 12 mounts.
Physical Activity will be subjective measured by use of a questionnaire regarding participants' everyday activity. Participants range their activity in several sports activities from never (1) to several days a week (4).The questionnaire is previous used in a national survey study regarding physical activity among children and adolescents in Norway.
Change in subjective answers of everyday activity from baseline, to 6 mounts and to 12 mounts.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thomas Johan Kibsgård, MD PhD, Oslo University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2016

Primary Completion (Anticipated)

January 1, 2022

Study Completion (Anticipated)

December 1, 2022

Study Registration Dates

First Submitted

March 15, 2017

First Submitted That Met QC Criteria

April 6, 2018

First Posted (Actual)

April 11, 2018

Study Record Updates

Last Update Posted (Actual)

September 20, 2021

Last Update Submitted That Met QC Criteria

September 17, 2021

Last Verified

September 1, 2021

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Scoliosis

3
Subscribe